# US 2006/0073523 A1 · Detecting cell membrane protein endocytosis

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0073523 A1
- Document ID: US20060073523A1
- Status: Published application
- Kind: A1
- Application number: 11/244,256
- Filed: 2005-10-04
- Published: 2006-04-06
- Earliest claimed: 2004-10-04
- Assignees: Discover, LLC
- Inventors: Yun-Jung Choi; Kun Peng; Linda Kauffman; Rajendra Singh
- Web page: https://patentgrep.com/patent/US20060073523A1

## CPC

- C12Q 1/37: involving peptidase or proteinase
- G01N 33/5005: {involving human or animal cells (immunoassay G01N33/56966; immunoassays of protozoa G01N33/56905; protozoa in screening assays C12Q1/025)}
- G01N 33/567: utilising isolate of tissue or organ as binding agent
- G01N 2333/924: acting on glycosyl compounds (3.2)
- G01N 2333/976: Trypsin; Chymotrypsin
- Y10S 435/962: Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
- Y10S 435/963: Methods of stopping an enzyme reaction or stabilizing the test materials
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- Y10S: TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS

## Abstract

Methods and reagents are provided for determining endocytosis, using a cell expressing an externally polypeptide labeled cell membrane receptor, and as a reagent an antibody to said label conjugated to a fragment of an enzyme fragment complementation pair. Compounds are tested for their effect on endocytosis by complexing the reagent with said cells, adding the test compound at any time in relation to the complexing, allowing any endocytosis to occur, proteolytically degrading external enzyme fragment, adding protease inhibitor and the complementary member of the enzyme fragment complementation pair and substrate. The product provides a detectable signal related to the amount of endocytosis that occurred. The method is readily automated as all steps can occur in a single vessel without separations and washings.

## Claims

### Claim 1

A method for determining endocytic changes of a cell membrane receptor in cells as a result of a change of environment of said cells, where said cells have a labeled cell membrane receptor, said label being a first member of a specific binding pair and external to said cell membrane, and employing as a reagent a complementary member of said specific binding pair joined to a member of an enzyme fragment complementation pair, which when complexed to a complementary enzyme fragment forms an active enzyme, said method comprising:
producing an environment to be tested for its effect on endocytosis for said cells to which said reagent is bound;
inactivating any of said member of said enzyme fragment complementation pair with an inactivating agent that does not adversely affect the activity of internalized member of said enzyme fragment complementation pair;
deactivating said inactivating agent;
lysing said cells;
adding said complementary enzyme fragment and substrate; and
determining the amount of product produced from said substrate;
wherein the amount of product is related to the amount of endocytosis of said cell membrane receptor.

### Claim 2 (depends on 1)

A method according to claim 1, wherein said inactivating agent is a protease and said deactivating employs a protease inhibitor.

### Claim 3 (depends on 1)

A method according to claim 1, wherein said label is a FLAG label and said complementary member of said binding pair is a FLAG antibody.

### Claim 4 (depends on 1)

A method according to claim 1, wherein said producing the environment is the inclusion of a test compound.

### Claim 5 (depends on 1)

A method according to claim 1, wherein said cells are a mammalian cell line genetically modified to express said labeled cell membrane receptor constitutively.

### Claim 6

A method for determining endocytic changes of a cell membrane receptor in mammalian cells as a result of a change of environment of said cells where said cells are genetically modified to express a labeled cell membrane receptor, said label being a polypeptide and a first member of a specific binding pair and external to said cell membrane, and employing as a reagent an antibody to said polypeptide joined to a β-galactosidase member of an enzyme fragment complementation pair which when complexed to the complementary enzyme fragment forms an active β-galactosidase, said method comprising:
adding to said cells suspended in a medium said reagent and incubating for sufficient time for said reagent to bind to said cell membrane receptor;
adding a test compound to said cells to determine the effect of said test compound on endocytosis of said cell membrane receptor;
degrading external β-galactosidase member of said enzyme fragment complementation pair with at least one protease;
deactivating said at least one protease;
lysing said cells by osmotic shock;
adding said complementary enzyme fragment and substrate; and
determining the amount of product produced from said substrate;
wherein the amount of product is related to the amount of endocytosis of said cell membrane receptor.

### Claim 7 (depends on 6)

A method according to claim 6, wherein said polypeptide is a FLAG polypeptide.

### Claim 8 (depends on 6)

A method according to claim 6, wherein said product gives a chemiluminescent signal.

### Claim 9 (depends on 6)

A method according to claim 6, wherein said at least one protease includes chymotrypsin.

### Claim 10

A kit comprising (a) a mammalian cell comprising an expression construct expressing a cell membrane receptor fused at its external end to a polypeptide label or (b) an expression construct expressing a cell membrane receptor fused at its external end to a polypeptide label; an antibody to said polypeptide label joined to a first β-galactosidase fragment; and the complementary second β-galactosidase fragment that when complexed with said first fragment forms an active enzyme.
